Hey mate, curious about your view for Canada - do you know if the Canadian revenues fall under the bracket that qualify for the milestone? I can’t remember. It’s possible that Acadia have sales milestones for North America hence Canadian sales will fall under it.
But I don’t think pricing will be that attractive in any region other than the USA. As we know the USA prices drugs in a crazy way.
Only once launched and approved across majority of the globe do I believe there will be a cumulative effect of the revenues on the share price.
Share Price, page-11029
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.01 |
Change
-1.640(8.79%) |
Mkt cap ! $2.174B | |||
| Open | High | Low | Value | Volume |
| $18.15 | $18.18 | $16.87 | $19.94M | 1.159M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 5090 | $17.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.10 | 995 | 1 |
View Market Depth
| Last trade - 16.10pm 05/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |